Trials / Unknown
UnknownNCT03411850
Sjogrens Syndrome Measured by Ultrasound
Disease Modification in Sjogrens Syndrome Measured by Ultrasound: A Pilot Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Arthritis & Rheumatism Associates, P.C. · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Ultrasound study focused on salivary gland outcomes in Sjogren's subjects
Detailed description
A 32 week ultrasound study for subject diagnosed with Sjogren's Syndrome. Subjects will receive Orencia (Abatacept) as intervention therapy during this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Orencia | FDA approved biologic |
| OTHER | Placebo |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2021-05-01
- Completion
- 2021-12-01
- First posted
- 2018-01-26
- Last updated
- 2021-05-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03411850. Inclusion in this directory is not an endorsement.